Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated … – EON: Enhanced Online News (press release)

Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated
EON: Enhanced Online News (press release)
“If granted, Orphan Drug Designation for our lead drug candidate, ADXS-HPV, would provide seven years of market exclusivity for ADXS-HPV, if it is approved by the FDA, tax credits on U.S. clinical trials, eligibility for orphan drug grants, and waiver

and more »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *